The aryl acylamidase activity is much more sensitive to Alzheimer drugs than the esterase activity of acetylcholinesterase in chicken embryonic brain

Biochimie

Volumn 91, Issue 9, 2009, Pages 1087-1094

  Rajesh, Ramanna V ^a   Chitra, Loganathan ^b   Layer, Paul G ^c   Boopathy, Rathanam ^b  

^a National Institute of Animal Science   (South Korea)

^b BHARATHIAR UNIVERSITY   (India)

^c DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Aryl acylamidase

Indexed keywords

1,5 BIS(4 ALLYLDIMETHYLAMMONIUMPHENYL)PENTAN 3 ONE DIBROMIDE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; ARYL ACYLAMIDASE; DONEPEZIL; DYFLOS; ESTERASE; HUPERZINE A; NOOTROPIC AGENT; TACRINE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CHICKEN; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARASYMPATHETIC INNERVATION; PATHOGENESIS; PROTEIN EXPRESSION; SYNAPTOGENESIS;

ACETYLCHOLINESTERASE; AMIDOHYDROLASES; ANIMALS; BENZENAMINIUM, 4,4'-(3-OXO-1,5-PENTANEDIYL)BIS(N,N-DIMETHYL-N-2-PROPENYL-), DIBROMIDE; BRAIN; CHICK EMBRYO; CHICKENS; CHOLINESTERASE INHIBITORS; ENZYME ACTIVATION; ESTERASES; INDANS; ISOFLUROPHATE; PIPERIDINES; TACRINE;

EID: 67651236274     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.07.004     Document Type: Article

References (49)

1. Soreq H., and Seidman S. Acetylcholinesterase: new roles for an old actor. Nat. Rev. Neurosci. 2 (2001) 294-302
2. Buznikov G.A. The role of nervous system mediators in individual development. Ontogenez 2 (1971) 5-13
3. Wolff J.R. Hinweise auf eine Doppelrolle von GABA als synaptischer Transmitter und als morphogenetischer Faktor. Verh. Dtsch. Zool. Ges. 72 (1979) 194-200
4. Lewis P.D. Neurohumoral influences on cell proliferation in brain development. Trends NeuroSci. 6 (1978) 158-159
5. Layer P.G., and Willbold E. Novel functions of cholinesterases in development physiology and disease. Prog. Histochem. Cytochem. 29 (1995) 1-94
6. Reiss Y., Layer P.G., and Kroger S. Butyrylcholinesterase-positive cells of the developing chicken retina that are noncholinergic and GABA-positive. Brain Res. Dev. 100 (1997) 62-72
7. Filogamo G., and Marchisio P.C. Acetylcholine system and neuronal development. Neurosci. Res. 4 (1971) 29-64
8. Layer P.G. Cholinesterases preceding major tracts in vertebrate neurogenesis. Bioessays 12 (1990) 415-420
9. Layer P.G. Cholinesterases during development of the avian nervous system. Mol. Cell. Neurobiol. 11 (1991) 7-33
10. Bigbee J.W., Sharma K.V., Chan E.L., and Bogler O. Evidence for the direct role of acetylcholinesterase in neurite outgrowth in primary dorsal root ganglion neurons. Brain Res. 861 (2000) 354-362
11. Anderson R.B., and Key B. Role of acetylcholinesterase in the development of axon tracts within the embryonic vertebrate brain. Int. J. Dev. Neurosci. 17 (1999) 787-793
12. Brimijoin S., and Koenigsberger C. Cholinesterases in neural development: new findings and toxicologic implications. Environ. Health Perspect. 107 Suppl. 1 (1999) 59-64
13. Birikh K.R., Sklan E.H., Shoham S., and Soreq H. Interaction of "readthrough" acetylcholinesterase with RACK1 and PKCβII correlates with intensified fear-induced conflict behavior. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 283-288
14. Scholl F.G., and Scheiffele P. Making connections: cholinesterase domain proteins in the CNS. Trends Neurosci. 26 (2003) 618-624
15. Balasubramanian A.S., and Bhanumathy C.D. Non-cholinergic functions of cholinesterases. FASEB J. 7 (1993) 1354-1358
16. Weitnauer E., Robitzki A., and Layer P.G. Aryl acylamidase activity exhibited by butyrylcholinesterase is higher in chick than in horse, but much lower than in fetal calf serum. Neurosci. Lett. 254 (1998) 153-156
17. Boopathy R., and Layer P.G. Aryl acylamidase activity on acetylcholinesterase is high during early chicken brain development. Protein J. 23 (2004) 325-333
18. Layer P.G., Weikert T., and Alber R. Cholinesterases regulate neurite outgrowth of chick nerve cells in vitro by means of a non-enzymatic mechanism. Cell Tissue Res. 273 (1993) 219-226
19. Dupree J., and Bigbee J. Retardation of neuritic outgrowth and cytoskeletal changes accompany acetylcholinesterase inhibitor treatment in cultured rat dorsal root ganglion neurons. Neurosci. Res. 39 (1994) 567-575
20. Alvarez A., Alarco R., Opazo C., et al. Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18 (1998) 3213-3223
21. Munoz F.J., and Inestrosa N.C. Neurotoxicity of acetylcholinesterase amyloid l-peptide aggregates is dependent on the type of AL peptide and the AChE concentration present in the complexes. FEBS 450 (1999) 205-209
22. George S.T., and Balasubramanian A.S. The identity of the serotonin-sensitive aryl acylamidase with acetylcholinesterase from human erythrocytes, sheep basal ganglia and electric eel. Eur. J. Biochem. 111 (1980) 511-524
23. Oommen A., and Balasubramanian A.S. The association of the serotonin-sensitive aryl acylamidase with acetylcholinesterase in the monkey brain. Eur. J. Biochem. 94 (1979) 135-143
24. Allebrant K.V., Rajesh R.V., Andermann P., and Layer P.G. Expression of acetylcholinesterase (AChE) and aryl acylamidase (AAA) during early zebrafish embryogenesis. Chem-Biol. Inter. 157-158 (2005) 353-434
25. Rajesh R.V., Balasubramanian A.S., and Boopathy R. Identification of serotonin sensitive aryl acylamidase activity with cobra venom acetylcholinesterase. Ind. J. Biochem. Biophy 40 (2003) 92-97
26. Wright C.I., Geula C., and Mesulam M.M. Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 683-686
27. Atack J.R., Perry E.K., Bonnam J.R., Candy J.M., and Perry R.H. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J. Neurochem. 47 (1986) 263-277
28. Arendt T., Bruckner M.K., Lange M., and Bigl V. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - a study of molecular forms. Neurochem. Int. 21 (1992) 381-396
29. Boopathy R., and Balasubramanian A.S. Chemical modification of acetylcholinesterase from eel and basal ganglia. Effect on acetylcholinesterase and aryl acylamidase activities. Eur. J. Biochem. 151 (1985) 351-360
30. Ellman G.L., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
31. Hoagland R.E., and Graf G. Nitroacetanilides as chromogenic substrates for assaying de-acetylating activity: the isolation and partial purification of aryl acylamidases from erepsin and tulip. Enzymologia 41 (1971) 313-319
32. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
33. Robertson R.T., and Yu J. Acetylcholinesterase and neural development: new tricks for an old dog?. News Physiol. Sci. 8 (1993) 266-272
34. Taylor P., Rieger F., and Greene L.A. Development of the multiple molecular forms of acetylcholinesterase in chick paravertebral sympathetic ganglia: an in vivo and in vitro study. Brain Res. 182 (1980) 383-396
35. Reichman E.F., and Beebe D.C. Acetylcholinesterase activity as a marker for the development of the ciliary epithelium in the chicken embryo. Exp. Eye Res. 51 (1990) 249-255
36. Ricardo D.M., Campos E.O., Federico D., and Intestrosa N.C. Developmental regulation of mouse brain monomeric acetylcholinesterase. Int. J. Dev. Neurosci. 16 (1998) 123-134
37. Duysen E.G., Bartels C.F., and Lockridge O. Wild-Type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese Hamster Ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity. J. Pharmacol. Exp. 302 (2002) 751-758
38. Small D.H., Michaelson S., and Sberna G. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28 (1996) 453-493
39. Layer P.G., and Sporns O. Spatiotemporal relationship of embryonic cholinesterases with cell proliferation in chicken brain and eye. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 284-288
40. Massoulié J., Pezzementi L., Bon S., Krejci E., and Vallette F.M. Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41 (1993) 31-91
41. Citralu T., Kronamn C., Velan V., and Shafferman A. Overloading and removal of N-glycosylation targets on human acetylcholinesterase: effects on glycan composition and circulatory residence time. Biochem. J. 363 (2002) 619-631
42. Weikert T., and Layer P.G. The carbohydrate epitope HNK-1 is present on all inactive, but not on all active forms of chicken butyrylcholinesterase. Neurosci. Lett. 176 (1994) 9-12
43. Weikert T., Ebert C., Rasched I., and Layer P.G. Novel inactive and distinctively glycosylated forms of butyrylcholinesterase from chicken serum. J. Neurochem. 63 (1994) 318-325
44. Nalivaeva N.N., and Turner A.J. Post-translational modifications of proteins: acetylcholinesterase as a model system. Proteomics 1 (2001) 735-747
45. Greenblatt H.M., Dvir H., Silman I., and Sussmann J.L. Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease. J. Mol. Neurosci. 20 (2003) 369-383
46. Geula C., and Mesulam M. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res. 498 (1998) 185-189
47. Ernst R.L., Hay J.W., Fenn C., Tinklenberg J., and Yesavage J.A. Cognitive function and the costs of Alzheimer disease. An exploratory study. Arch. Neurol. 54 (1997) 687-693
48. Darvesh S., Walsh R., and Martin E. Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases. Cell Mol. Neurobiol. 23 (2003) 93-100
49. Kosasa T., Kuriya Y., Matsui K., and Yamanishi Y. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats. Eur. J. Pharmacol. 38 (2000) 173-179